Clinical Features, Diagnosis, Pathology

Part of the Pediatric Oncology book series (PEDIATRICO)


This chapter will review the clinical and histopathologic features associated with the presentation and diagnosis of retinoblastoma. A thorough appreciation of the differential and a detailed clinical assessments is the cornerstone of arriving at the proper diagnosis. Unlike most cancers, retinoblastoma is unique, as tissue is generally not necessary for diagnostic and treatment purposes. However, once the eye is enucleated, the histopathologic features guide therapy and prognosis. We will review ancillary testing that can assist the clinician and address pathologic features that can affect patient prognosis.


Optic Nerve Lamina Cribrosa Neovascular Glaucoma Ancillary Testing Choroidal Invasion 


  1. Ajaiyeoba AI, Olusanya BA, Komolafe OO, Akang EE (2007) Clinical presentation of retinoblastoma: a tertiary hospital experience. Afr J Med Med Sci 36(3):289-290PubMedGoogle Scholar
  2. Amoaku WM, Willshaw HE, Parkes SE, Shah KJ, Mann JR (1996) Trilateral retinoblastoma. A report of five patients. Cancer 78(4):858-863PubMedCrossRefGoogle Scholar
  3. Antoneli CB, Ribeiro Kde C, Sakamoto LH, Chojniak MM, Novaes PE, Arias VE (2007) Trilateral retinoblastoma. Pediatr Blood Cancer 48(3):306-310PubMedCrossRefGoogle Scholar
  4. Apte RS, Harbour JW (2007) Inhibiting angiogenesis in retinoblastoma. Ophthalmic Res 39(4):188-190PubMedCrossRefGoogle Scholar
  5. Apushkin MA, Apushkin MA, Shapiro MJ, Mafee MF (2005) Retinoblastoma and simulating lesions: role of imaging. Neuroimaging Clin N Am 15(1):49-67PubMedCrossRefGoogle Scholar
  6. Azar D, Donaldson C, Dalla-Pozza L (2003) Questioning the need for routine bone marrow aspiration and lumbar puncture in patients with retinoblastoma. Clin Experiment Ophthalmol 31(1):57-60PubMedCrossRefGoogle Scholar
  7. Badhu B, Sah SP, Thakur SK, Dulal S, Kumar S, Sood A, Das H, Sah RP (2005) Clinical presentation of retinoblastoma in Eastern Nepal. Clin Experiment Ophthalmol 33(4):386-389PubMedCrossRefGoogle Scholar
  8. Baez KA, Ulbig MW, Cater J, Shields CL, Shields JA (1994) Iris neovascularization, increased intraocular pressure and vitreous hemorrhage as risk factors for invasion of the optic nerve and choroid in children with retinoblastoma. Ophthalmologe 91(6):796-800PubMedGoogle Scholar
  9. Bagley LJ, Hurst RW, Zimmerman RA, Shields JA, Shields CL, De Potter P (1996) Imaging in the trilateral retinoblastoma syndrome. Neuroradiology 38(2):166-170PubMedCrossRefGoogle Scholar
  10. Balasubramanya R, Pushker N, Bajaj MS, Ghose S, Kashyap S, Rani A (2004) Atypical presentations of retinoblastoma. J Pediatr Ophthalmol Strabismus 41(1):18-24PubMedGoogle Scholar
  11. Balmer A, Munier F (1999) Leukokoria in a child: emergency and challenge. Klin Monatsbl Augenheilkd 214(5):332-335PubMedCrossRefGoogle Scholar
  12. Bowman RJ, Mafwiri M, Luthert P, Luande J, Wood M (2008) Outcome of retinoblastoma in east Africa. Pediatr Blood Cancer 50(1):160-162PubMedCrossRefGoogle Scholar
  13. Brisse HJ, Guesmi M, Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Desjardins L, Doz F, Asselain B, Bours D, Neuenschwander S (2007) Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison. Pediatr Radiol 37(7):649-656PubMedCrossRefGoogle Scholar
  14. Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ, Grabowski E, Leal-Leal C, Rodríguez-Galindo C, Schvartzman E, Popovic MB, Kremens B, Meadows AT, Zucker JM (2006) A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 47(6):801-805PubMedCrossRefGoogle Scholar
  15. Chantada GL, Guitter MR, Fandiño AC, Raslawski EC, de Davila MT, Vaiani E, Scopinaro MJ (2009) Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve. Pediatr Blood Cancer 52(2):218-222PubMedCrossRefGoogle Scholar
  16. Chévez-Barrios P, Eagle RC, Marbach P (2007) Histological features and risks for metastatic spread of retinoblastoma. In: Singh AD, Damato B, Pe’er J, Murphree AL, Perry JD (eds) Clinical ocular oncology, 1st edn. Elsevier, Saunders, London Section 6-77Google Scholar
  17. Chong EM, Coffee RE, Chintagumpala M, Hurwitz RL, Hurwitz MY, Chevez-Barrios P (2006) Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med 130(11):1669-1672PubMedGoogle Scholar
  18. Croxatto JO, Fernandez Meijide R, Malbran ES (1983) Retinoblastoma masquerading as ocular inflammation. Ophthalmologica 186:48-53PubMedCrossRefGoogle Scholar
  19. Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, Marrano P, Corson TW, Eagle RC Jr, Squire JA, Gallie BL (2008) Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 17(10):1363-1372PubMedCrossRefGoogle Scholar
  20. Duncan JL, Scott IU, Murray TG, Gombos DS, van Quill K, O’Brien JM (2001) Routine neuroimaging in retinoblastoma for the detection of intracranial tumors. Arch Ophthalmol 119(3):450-452PubMedGoogle Scholar
  21. Fernandes BF, Odashiro AN, Maloney S, Zajdenweber ME, Lopes AG, Burnier MN Jr (2006) Clinical-histopathological correlation in a case of Coats’ disease. Diagn Pathol 1:24PubMedCrossRefGoogle Scholar
  22. Field M, Shanley S, Kirk J (2007) Inherited cancer susceptibility syndromes in paediatric practice. J Paediatr Child Health 43(4):219-229PubMedCrossRefGoogle Scholar
  23. Gündüz K, Müftüoglu O, Günalp I, Unal E, Taçyildiz N (2006) Metastatic retinoblastoma clinical features, treatment, and prognosis. Ophthalmology 113(9):1558-1566 Epub 2006 Jul 7PubMedCrossRefGoogle Scholar
  24. Hurwitz RL, Chévez-Barrios P, Chintagumpala M, Shields C, Shields J (2002) Retinoblastoma. In: Pizzo PA, Poplack D (eds) Principles and practice of pediatric oncology, 4th edn. Lippincott-Raven, Philadelphia, pp 825-846 (4th 2002 and 5th edn 2006)Google Scholar
  25. Imhof SM, Moll AC, Schouten-van Meeteren AY (2006) Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands. Br J Ophthalmol 90(7):875-878 Epub 2006 Apr 13PubMedCrossRefGoogle Scholar
  26. Jia RB, Zhang P, Zhou YX, Song X, Liu HY, Wang LZ, Luo M, Lu J, Ge SF, Fan XQ (2007) VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma. Ophthalmic Res 39(2):108-115PubMedCrossRefGoogle Scholar
  27. Jockovich ME, Suarez F, Alegret A, Piña Y, Hayden B, Cebulla C, Feuer W, Murray TG (2007) Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model. Invest Ophthalmol Vis Sci 48(12):5371-5376PubMedCrossRefGoogle Scholar
  28. Karcioglu ZA (2002) Fine needle aspiration biopsy (FNAB) for retinoblastoma. Retina 22(6):707-710PubMedCrossRefGoogle Scholar
  29. Karcioglu ZA, Al Mesfer SA, Abboud E et al (1997) Workup for metastatic retinoblastoma. A review of 261 patients. Ophthalmology 104:307-312PubMedGoogle Scholar
  30. Kiss S, Leiderman YI, Mukai S (2008) Diagnosis, classification, and treatment of retinoblastoma. Int Ophthalmol Clin 48(2):135-147PubMedCrossRefGoogle Scholar
  31. Kivelä T (1999) Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol 17(6):1829-1837PubMedGoogle Scholar
  32. Kopelman JE, McLean IW, Rosenby SH (1987) Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology 94:371-377PubMedGoogle Scholar
  33. Maat-Kievit JA, Oepkes D, Hartwig NG, Vermeij-Keers C, van Kamp IL, van de Kamp JJ (1993) A large retinoblastoma detected in a fetus at 21 weeks of gestation. Prenat Diagn 13(5):377-384PubMedCrossRefGoogle Scholar
  34. Marback EF, Arias VE, Paranhos A Jr, Soares FA, Murphree AL, Erwenne CM (2003) Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. Br J Ophthalmol 87(10):1224-1228PubMedCrossRefGoogle Scholar
  35. Margo C, Hidayat A, Kopelman J, Zimmerman LE (1983) Retinocytoma. A benign variant of retinoblastoma. Arch Ophthalmol 101(10):1519-1531PubMedCrossRefGoogle Scholar
  36. McLean IW, Burnier M, Zimmerman L, Jakobiec F (1994) Tumors of the retina. In: McLean IW, Burnier MN, Zimmerman LE, Jakobiec FA (eds) Atlas of tumor pathology. Tumors of the eye and ocular adnexa. Armed Forced Institute of Pathology, Washington, DC, pp 100-135Google Scholar
  37. Nork TM, Schwartz TL, Doshi HM et al (1995) Retinoblastoma. Cell of origin. Arch Ophthalmol 113:791-802PubMedCrossRefGoogle Scholar
  38. O’Brien JM (2001) Retinoblastoma: clinical presentation and the role of neuroimaging. AJNR Am J Neuroradiol 22(3):426-428PubMedGoogle Scholar
  39. Paulino AC (1999) Trilateral retinoblastoma: is the location of the intracranial tumor important? Cancer 86(1):135-141PubMedCrossRefGoogle Scholar
  40. Pierro L, Brancato R, Capoferri C (1993) Prenatal detection and early diagnosis of hereditary retinoblastoma in a family. Ophthalmologica 207(2):106-111PubMedCrossRefGoogle Scholar
  41. Rao A, Rothman J, Nichols KE (2008) Genetic testing and tumor surveillance for children with cancer predisposition syndromes. Curr Opin Pediatr 20(1):1-7PubMedCrossRefGoogle Scholar
  42. Robertson DM (1997) Fine-needle biopsy and retinoblastoma. Ophthalmology 104(4):567-568PubMedGoogle Scholar
  43. Shanmugam MP, Biswas J (1997) Fine needle aspiration biopsy in the diagnosis of intraocular mass lesions. Indian J Ophthalmol 45(2):105-108PubMedGoogle Scholar
  44. Shields JA, Shields CL, Eagle RC et al (1988) Spontaneous pseudohypopyon secondary to diffuse infiltrating retinoblastoma. Arch Ophthalmol 106:1301-1302PubMedCrossRefGoogle Scholar
  45. Shields CL, Shields JA, Shah P (1991) Retinoblastoma in older children. Ophthalmology 98(3):395-399PubMedGoogle Scholar
  46. Shields JA, Shields CL, Honavar SG, Demirci H (2001a) Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol 131(5):561-571PubMedCrossRefGoogle Scholar
  47. Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF (2001b) Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol 119(9):1269-1272PubMedCrossRefGoogle Scholar
  48. Singh AD, Santos CM, Shields CL, Shields JA, Eagle RC Jr (2000) Observations on 17 patients with retinocytoma. Arch Ophthalmol 118(2):199-205PubMedCrossRefGoogle Scholar
  49. Smith JH, Murray TG, Fulton L, O’Brien JM (2000) Siblings of retinoblastoma patients: are we underestimating their risk? Am J Ophthalmol 129(3):396-398PubMedCrossRefGoogle Scholar
  50. Spencer WH (1975) Optic nerve extension of intraocular neoplasms. Am J Ophthalmol 80:465-471PubMedGoogle Scholar
  51. Sun MH, Kao LY, Kuo YH (2003) Persistent hyperplastic primary vitreous: magnetic resonance imaging and clinical findings. Chang Gung Med J 26(4):269-276PubMedGoogle Scholar
  52. Tosi P, Cintorino M, Toti P et al (1989) Histopathological evaluation for the prognosis of retinoblastoma. Ophthalmic Paediatr Genet 10:173-177PubMedCrossRefGoogle Scholar
  53. Ts’o MO, Fine BS, Zimmerman LE (1970a) The nature of retinoblastoma. II. Photoreceptor differentiation: an electron microscopic study. Am J Ophthalmol 69:350-359PubMedGoogle Scholar
  54. Ts’o MO, Zimmerman LE, Fine BS (1970b) The nature of retinoblastoma. I. Photoreceptor differentiation: a clinical and histopathologic study. Am J Ophthalmol 69:339-349PubMedGoogle Scholar
  55. Wallach M, Balmer A, Munier F, Houghton S, Pampallona S, von der Weid N, Beck-Popovic M, Swiss Pediatric Oncology Group, Swiss Childhood Cancer Registry (2006) Swiss patients with retinoblastoma treated from 1963 to 2004. Pediatrics 118(5):e1493-e1498PubMedCrossRefGoogle Scholar
  56. Wolach B, Sinnreich Z, Uziel Y, Gotesman G, Pomerantz A (1995) Toxocariasis: a diagnostic dilemma. Isr J Med Sci 31(11):689-692PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of PathologyThe Methodist Hospital Weill College of Medicine of Cornell UniversityHoustonUSA
  2. 2.Department of Head and Neck Surgery Section of OphthalmologyThe University of Texas MD. Anderson Cancer CenterHoustonUSA

Personalised recommendations